<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33893069</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2213-2317</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>42</Volume>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Redox biology</Title>
          <ISOAbbreviation>Redox Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Redox regulation of the insulin signalling pathway.</ArticleTitle>
        <Pagination>
          <StartPage>101964</StartPage>
          <MedlinePgn>101964</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">101964</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.redox.2021.101964</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S2213-2317(21)00112-9</ELocationID>
        <Abstract>
          <AbstractText>The peptide hormone insulin is a key regulator of energy metabolism, proliferation and survival. Binding of insulin to its receptor activates the PI3K/AKT signalling pathway, which mediates fundamental cellular responses. Oxidants, in particular H<sub>2</sub>O<sub>2</sub>, have been recognised as insulin-mimetics. Treatment of cells with insulin leads to increased intracellular H<sub>2</sub>O<sub>2</sub> levels affecting the activity of downstream signalling components, thereby amplifying insulin-mediated signal transduction. Specific molecular targets of insulin-stimulated H<sub>2</sub>O<sub>2</sub> include phosphatases and kinases, whose activity can be altered via redox modifications of critical cysteine residues. Over the past decades, several of these redox-sensitive cysteines have been identified and their impact on insulin signalling evaluated. The aim of this review is to summarise the current knowledge on the redox regulation of the insulin signalling pathway.</AbstractText>
          <CopyrightInformation>Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lennicke</LastName>
            <ForeName>Claudia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>MRC London Institute of Medical Sciences, Du Cane Road, London, W12 0NN, UK; Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cochemé</LastName>
            <ForeName>Helena M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>MRC London Institute of Medical Sciences, Du Cane Road, London, W12 0NN, UK; Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. Electronic address: helena.cocheme@lms.mrc.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MC_UP_1102/10</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MC-A654-5QB90</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>04</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Redox Biol</MedlineTA>
        <NlmUniqueID>101605639</NlmUniqueID>
        <ISSNLinking>2213-2317</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>BBX060AN9V</RegistryNumber>
          <NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019869" MajorTopicYN="Y">Phosphatidylinositol 3-Kinases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Cysteine post-translational modification</Keyword>
        <Keyword MajorTopicYN="Y">FOXO</Keyword>
        <Keyword MajorTopicYN="Y">H(2)O(2)</Keyword>
        <Keyword MajorTopicYN="Y">Insulin signalling</Keyword>
        <Keyword MajorTopicYN="Y">NRF2</Keyword>
        <Keyword MajorTopicYN="Y">ROS</Keyword>
        <Keyword MajorTopicYN="Y">Redox regulation</Keyword>
        <Keyword MajorTopicYN="Y">Type-2 diabetes</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that there are no competing interests associated with the manuscript.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>24</Day>
          <Hour>5</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33893069</ArticleId>
        <ArticleId IdType="pmc">PMC8113030</ArticleId>
        <ArticleId IdType="doi">10.1016/j.redox.2021.101964</ArticleId>
        <ArticleId IdType="pii">S2213-2317(21)00112-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Narasimhan S.D., Yen K., Tissenbaum H.A. Converging pathways in lifespan regulation. Curr. Biol. 2009;19:R657–R666. doi: 10.1016/j.cub.2009.06.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cub.2009.06.013</ArticleId>
            <ArticleId IdType="pmc">PMC3109866</ArticleId>
            <ArticleId IdType="pubmed">19674551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddle K. Signalling by insulin and IGF receptors: supporting acts and new players. J. Mol. Endocrinol. 2011;47:R1–R10. doi: 10.1530/JME-11-0022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/JME-11-0022</ArticleId>
            <ArticleId IdType="pubmed">21498522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolb H., Kempf K., Röhling M., Martin S. Insulin: too much of a good thing is bad. BMC Med. 2020;18:224. doi: 10.1186/s12916-020-01688-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12916-020-01688-6</ArticleId>
            <ArticleId IdType="pmc">PMC7441661</ArticleId>
            <ArticleId IdType="pubmed">32819363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Diabetes Association  Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90. doi: 10.2337/dc14-S081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc14-S081</ArticleId>
            <ArticleId IdType="pubmed">24357215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., Shaw J.E., Bright D., Williams R. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabres.2019.107843</ArticleId>
            <ArticleId IdType="pubmed">31518657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>NCD Risk Factor Collaboration (NCD-RisC)  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–1530. doi: 10.1016/S0140-6736(16)00618-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00618-8</ArticleId>
            <ArticleId IdType="pmc">PMC5081106</ArticleId>
            <ArticleId IdType="pubmed">27061677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trikkalinou A., Papazafiropoulou A.K., Melidonis A. Diabetes and quality of life. World J. Diabetes. 2017;8:120–129. doi: 10.4239/wjd.v8.i4.120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4239/wjd.v8.i4.120</ArticleId>
            <ArticleId IdType="pmc">PMC5394731</ArticleId>
            <ArticleId IdType="pubmed">28465788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts S.B., Das S.K., Suen V.M.M., Pihlajamäki J., Kuriyan R., Steiner-Asiedu M., Taetzsch A., Anderson A.K., Silver R.E., Barger K., Krauss A., Karhunen L., Zhang X., Hambly C., Schwab U., Triffoni-Melo A.D.T., Fassini P.G., Taylor S.F., Economos C., Kurpad A.V., Speakman J.R. Measured energy content of frequently purchased restaurant meals: multi-country cross sectional study. BMJ. 2018;363 doi: 10.1136/bmj.k4864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.k4864</ArticleId>
            <ArticleId IdType="pmc">PMC6290458</ArticleId>
            <ArticleId IdType="pubmed">30541752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall K.D. Did the food environment cause the obesity epidemic? Obesity. 2018;26:11–13. doi: 10.1002/oby.22073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/oby.22073</ArticleId>
            <ArticleId IdType="pmc">PMC5769871</ArticleId>
            <ArticleId IdType="pubmed">29265772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhuri R., Krycer J.R., Fazakerley D.J., Fisher-Wellman K.H., Su Z., Hoehn K.L., Yang J.Y.H., Kuncic Z., Vafaee F., James D.E. The transcriptional response to oxidative stress is part of, but not sufficient for, insulin resistance in adipocytes. Sci. Rep. 2018;8:1774. doi: 10.1038/s41598-018-20104-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-20104-x</ArticleId>
            <ArticleId IdType="pmc">PMC5789081</ArticleId>
            <ArticleId IdType="pubmed">29379070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820. doi: 10.1038/414813a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/414813a</ArticleId>
            <ArticleId IdType="pubmed">11742414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002;23:599–622. doi: 10.1210/er.2001-0039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2001-0039</ArticleId>
            <ArticleId IdType="pubmed">12372842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang Y.C., Chuang L.M. The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am. J. Transl. Res. 2010;2:316–331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2892404</ArticleId>
            <ArticleId IdType="pubmed">20589170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J.A., Wei Y., Sowers J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 2008;102:401–414. doi: 10.1161/CIRCRESAHA.107.165472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.107.165472</ArticleId>
            <ArticleId IdType="pmc">PMC2963150</ArticleId>
            <ArticleId IdType="pubmed">18309108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parvez S., Long M.J.C., Poganik J.R., Aye Y. Redox signaling by reactive electrophiles and oxidants. Chem. Rev. 2018;118:8798–8888. doi: 10.1021/acs.chemrev.7b00698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.chemrev.7b00698</ArticleId>
            <ArticleId IdType="pmc">PMC6158072</ArticleId>
            <ArticleId IdType="pubmed">30148624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1–13. doi: 10.1042/BJ20081386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20081386</ArticleId>
            <ArticleId IdType="pmc">PMC2605959</ArticleId>
            <ArticleId IdType="pubmed">19061483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004;4:181–189. doi: 10.1038/nri1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri1312</ArticleId>
            <ArticleId IdType="pubmed">15039755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Dam L., Dansen T.B. Cross-talk between redox signalling and protein aggregation. Biochem. Soc. Trans. 2020;48:379–397. doi: 10.1042/BST20190054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BST20190054</ArticleId>
            <ArticleId IdType="pmc">PMC7200635</ArticleId>
            <ArticleId IdType="pubmed">32311028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins Y., Chouchani E.T., James A.M., Menger K.E., Cochemé H.M., Murphy M.P. Mitochondrial redox signalling at a glance. J. Cell Sci. 2012;125:801–806. doi: 10.1242/jcs.098475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.098475</ArticleId>
            <ArticleId IdType="pubmed">22448036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cremers C.M., Jakob U. Oxidant sensing by reversible disulfide bond formation. J. Biol. Chem. 2013;288:26489–26496. doi: 10.1074/jbc.R113.462929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.R113.462929</ArticleId>
            <ArticleId IdType="pmc">PMC3772196</ArticleId>
            <ArticleId IdType="pubmed">23861395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Go Y.M., Chandler J.D., Jones D.P. The cysteine proteome. Free Radic. Biol. Med. 2015;84:227–245. doi: 10.1016/j.freeradbiomed.2015.03.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.03.022</ArticleId>
            <ArticleId IdType="pmc">PMC4457640</ArticleId>
            <ArticleId IdType="pubmed">25843657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Putker M., Vos H.R., van Dorenmalen K., de Ruiter H., Duran A.G., Snel B., Burgering B.M.T., Vermeulen M., Dansen T.B. Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling. Antioxid. Redox Signal. 2015;22:15–28. doi: 10.1089/ars.2014.6056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2014.6056</ArticleId>
            <ArticleId IdType="pmc">PMC4270166</ArticleId>
            <ArticleId IdType="pubmed">25069953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paulsen C.E., Carroll K.S. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem. Rev. 2013;113:4633–4679. doi: 10.1021/cr300163e.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cr300163e</ArticleId>
            <ArticleId IdType="pmc">PMC4303468</ArticleId>
            <ArticleId IdType="pubmed">23514336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennicke C., Rahn J., Lichtenfels R., Wessjohann L.A., Seliger B. Hydrogen peroxide - production, fate and role in redox signaling of tumor cells. Cell Commun. Signal. 2015;13:39. doi: 10.1186/s12964-015-0118-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12964-015-0118-6</ArticleId>
            <ArticleId IdType="pmc">PMC4570748</ArticleId>
            <ArticleId IdType="pubmed">26369938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forman H.J., Zhang H., Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Aspects Med. 2009;30:1–12. doi: 10.1016/j.mam.2008.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2008.08.006</ArticleId>
            <ArticleId IdType="pmc">PMC2696075</ArticleId>
            <ArticleId IdType="pubmed">18796312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bindoli A., Fukuto J.M., Forman H.J. Thiol chemistry in peroxidase catalysis and redox signaling. Antioxid. Redox Signal. 2008;10:1549–1564. doi: 10.1089/ars.2008.2063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2008.2063</ArticleId>
            <ArticleId IdType="pmc">PMC2693905</ArticleId>
            <ArticleId IdType="pubmed">18479206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mailloux R.J. Protein S-glutathionylation reactions as a global inhibitor of cell metabolism for the desensitization of hydrogen peroxide signals. Redox Biol. 2020;32:101472. doi: 10.1016/j.redox.2020.101472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2020.101472</ArticleId>
            <ArticleId IdType="pmc">PMC7076094</ArticleId>
            <ArticleId IdType="pubmed">32171726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poole L.B. The basics of thiols and cysteines in redox biology and chemistry. Free Radic. Biol. Med. 2015;80:148–157. doi: 10.1016/j.freeradbiomed.2014.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.11.013</ArticleId>
            <ArticleId IdType="pmc">PMC4355186</ArticleId>
            <ArticleId IdType="pubmed">25433365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao H., Jedrychowski M.P., Schweppe D.K., Huttlin E.L., Yu Q., Heppner D.E., Li J., Long J., Mills E.L., Szpyt J., He Z., Du G., Garrity R., Reddy A., Vaites L.P., Paulo J.A., Zhang T., Gray N.S., Gygi S.P., Chouchani E.T. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell. 2020;180:968–983. doi: 10.1016/j.cell.2020.02.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2020.02.012</ArticleId>
            <ArticleId IdType="pubmed">32109415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su Z., Burchfield J.G., Yang P., Humphrey S.J., Yang G., Francis D., Yasmin S., Shin S.Y., Norris D.M., Kearney A.L., Astore M.A., Scavuzzo J., Fisher-Wellman K.H., Wang Q.P., Parker B.L., Neely G.G., Vafaee F., Chiu J., Yeo R., Hogg P.J., Fazakerley D.J., Nguyen L.K., Kuyucak S., James D.E. Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Nat. Commun. 2019;10:5486. doi: 10.1038/s41467-019-13114-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-019-13114-4</ArticleId>
            <ArticleId IdType="pmc">PMC6889415</ArticleId>
            <ArticleId IdType="pubmed">31792197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corcoran A., Cotter T.G. Redox regulation of protein kinases. FEBS J. 2013;280:1944–1965. doi: 10.1111/febs.12224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.12224</ArticleId>
            <ArticleId IdType="pubmed">23461806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antunes F., Brito P.M. Quantitative biology of hydrogen peroxide signaling. Redox Biol. 2017;13:1–7. doi: 10.1016/j.redox.2017.04.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2017.04.039</ArticleId>
            <ArticleId IdType="pmc">PMC5436100</ArticleId>
            <ArticleId IdType="pubmed">28528123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wood Z.A., Poole L.B., Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 2003;300:650–653. doi: 10.1126/science.1080405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1080405</ArticleId>
            <ArticleId IdType="pubmed">12714747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobotta M.C., Liou W., Stöcker S., Talwar D., Oehler M., Ruppert T., Scharf A.N.D., Dick T.P. Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. Nat. Chem. Biol. 2015;11:64–70. doi: 10.1038/nchembio.1695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.1695</ArticleId>
            <ArticleId IdType="pubmed">25402766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peskin A.V., Pace P.E., Winterbourn C.C. Enhanced hyperoxidation of peroxiredoxin 2 and peroxiredoxin 3 in the presence of bicarbonate/CO2. Free Radic. Biol. Med. 2019;145:1–7. doi: 10.1016/j.freeradbiomed.2019.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.09.010</ArticleId>
            <ArticleId IdType="pubmed">31521665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dagnell M., Cheng Q., Rizvi S.H.M., Pace P.E., Boivin B., Winterbourn C.C., Arnér E.S.J. Bicarbonate is essential for protein-tyrosine phosphatase 1B (PTP1B) oxidation and cellular signaling through EGF-triggered phosphorylation cascades. J. Biol. Chem. 2019;294:12330–12338. doi: 10.1074/jbc.RA119.009001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA119.009001</ArticleId>
            <ArticleId IdType="pmc">PMC6699834</ArticleId>
            <ArticleId IdType="pubmed">31197039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoehn K.L., Hohnen-Behrens C., Cederberg A., Wu L.E., Turner N., Yuasa T., Ebina Y., James D.E. IRS1-independent defects define major nodes of insulin resistance. Cell Metab. 2008;7:421–433. doi: 10.1016/j.cmet.2008.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2008.04.005</ArticleId>
            <ArticleId IdType="pmc">PMC2443409</ArticleId>
            <ArticleId IdType="pubmed">18460333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Till J.H., Ablooglu A.J., Frankel M., Bishop S.M., Kohanski R.A., Hubbard S.R. Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism. J. Biol. Chem. 2001;276:10049–10055. doi: 10.1074/jbc.M010161200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M010161200</ArticleId>
            <ArticleId IdType="pubmed">11124964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemmon M.A., Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117–1134. doi: 10.1016/j.cell.2010.06.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2010.06.011</ArticleId>
            <ArticleId IdType="pmc">PMC2914105</ArticleId>
            <ArticleId IdType="pubmed">20602996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fayard E., Xue G., Parcellier A., Bozulic L., Hemmings B.A. Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr. Top. Microbiol. Immunol. 2010;346:31–56. doi: 10.1007/82_2010_58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/82_2010_58</ArticleId>
            <ArticleId IdType="pubmed">20517722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dummler B., Hemmings B.A. Physiological roles of PKB/Akt isoforms in development and disease. Biochem. Soc. Trans. 2007;35:231–235. doi: 10.1042/BST0350231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BST0350231</ArticleId>
            <ArticleId IdType="pubmed">17371246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ) Science. 2001;292:1728–1731. doi: 10.1126/science.292.5522.1728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.292.5522.1728</ArticleId>
            <ArticleId IdType="pubmed">11387480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Q.L., Park J.G., Jiang Z.Y., Holik J.J., Mitra P., Semiz S., Guilherme A., Powelka A.M., Tang X., Virbasius J., Czech M.P. Analysis of insulin signalling by RNAi-based gene silencing. Biochem. Soc. Trans. 2004;32:817–821. doi: 10.1042/BST0320817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BST0320817</ArticleId>
            <ArticleId IdType="pubmed">15494023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George S., Rochford J.J., Wolfrum C., Gray S.L., Schinner S., Wilson J.C., Soos M.A., Murgatroyd P.R., Williams R.M., Acerini C.L., Dunger D.B., Barford D., Umpleby A.M., Wareham N.J., Davies H.A., Schafer A.J., Stoffel M., O'Rahilly S., Barroso I. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004;304:1325–1328. doi: 10.1126/science.1096706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1096706</ArticleId>
            <ArticleId IdType="pmc">PMC2258004</ArticleId>
            <ArticleId IdType="pubmed">15166380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussain K., Challis B., Rocha N., Payne F., Minic M., Thompson A., Daly A., Scott C., Harris J., Smillie B.J.L., Savage D.B., Ramaswami U., De Lonlay P., O'Rahilly S., Barroso I., Semple R.K. An activating mutation of AKT2 and human hypoglycemia. Science. 2011;334:474. doi: 10.1126/science.1210878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1210878</ArticleId>
            <ArticleId IdType="pmc">PMC3204221</ArticleId>
            <ArticleId IdType="pubmed">21979934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hale A.J., Ter Steege E., den Hertog J. Recent advances in understanding the role of protein-tyrosine phosphatases in development and disease. Dev. Biol. 2017;428:283–292. doi: 10.1016/j.ydbio.2017.03.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2017.03.023</ArticleId>
            <ArticleId IdType="pubmed">28728679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.-B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 2000;20:5479–5489. doi: 10.1128/mcb.20.15.5479-5489.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.20.15.5479-5489.2000</ArticleId>
            <ArticleId IdType="pmc">PMC85999</ArticleId>
            <ArticleId IdType="pubmed">10891488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>González-Rodríguez Á., Más-Gutierrez J.A., Mirasierra M., Fernandez-Pérez A., Lee Y.J., Ko H.J., Kim J.K., Romanos E., Carrascosa J.M., Ros M., Vallejo M., Rondinone C.M., Valverde Á.M. Essential role of protein tyrosine phosphatase 1B in obesity-induced inflammation and peripheral insulin resistance during aging. Aging Cell. 2012;11:284–296. doi: 10.1111/j.1474-9726.2011.00786.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1474-9726.2011.00786.x</ArticleId>
            <ArticleId IdType="pmc">PMC3306541</ArticleId>
            <ArticleId IdType="pubmed">22221695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kipfer-Coudreau S., Eberlé D., Sahbatou M., Bonhomme A., Guy-Grand B., Froguel P., Galan P., Basdevant A., Clément K. Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia. 2004;47:1278–1284. doi: 10.1007/s00125-004-1432-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-004-1432-5</ArticleId>
            <ArticleId IdType="pubmed">15235769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paglialunga S., Ludzki A., Root-McCaig J., Holloway G.P. In adipose tissue, increased mitochondrial emission of reactive oxygen species is important for short-term high-fat diet-induced insulin resistance in mice. Diabetologia. 2015;58:1071–1080. doi: 10.1007/s00125-015-3531-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-015-3531-x</ArticleId>
            <ArticleId IdType="pubmed">25754553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boden G., Homko C., Barrero C.A., Stein T.P., Chen X., Cheung P., Fecchio C., Koller S., Merali S. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Sci. Transl. Med. 2015;7:304re7. doi: 10.1126/scitranslmed.aac4765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.aac4765</ArticleId>
            <ArticleId IdType="pmc">PMC5600191</ArticleId>
            <ArticleId IdType="pubmed">26355033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClung J.P., Roneker C.A., Mu W., Lisk D.J., Langlais P., Liu F., Lei X.G. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. U.S.A. 2004;101:8852–8857. doi: 10.1073/pnas.0308096101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0308096101</ArticleId>
            <ArticleId IdType="pmc">PMC428436</ArticleId>
            <ArticleId IdType="pubmed">15184668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldstein B.J., Mahadev K., Wu X., Zhu L., Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal. 2005;7:1021–1031. doi: 10.1089/ars.2005.7.1021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2005.7.1021</ArticleId>
            <ArticleId IdType="pmc">PMC1434604</ArticleId>
            <ArticleId IdType="pubmed">15998257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Contreras-Ferrat A., Llanos P., Vásquez C., Espinosa A., Osorio-Fuentealba C., Arias-Calderon M., Lavandero S., Klip A., Hidalgo C., Jaimovich E. Insulin elicits a ROS-activated and an IP3-dependent Ca2+ release, which both impinge on GLUT4 translocation. J. Cell Sci. 2014;127:1911–1923. doi: 10.1242/jcs.138982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.138982</ArticleId>
            <ArticleId IdType="pubmed">24569874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loh K., Deng H., Fukushima A., Cai X., Boivin B., Galic S., Bruce C., Shields B.J., Skiba B., Ooms L.M., Stepto N., Wu B., Mitchell C.A., Tonks N.K., Watt M.J., Febbraio M.A., Crack P.J., Andrikopoulos S., Tiganis T. Reactive oxygen species enhance insulin sensitivity. Cell Metab. 2009;10:260–272. doi: 10.1016/j.cmet.2009.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2009.08.009</ArticleId>
            <ArticleId IdType="pmc">PMC2892288</ArticleId>
            <ArticleId IdType="pubmed">19808019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>May J.M., Haën C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem. 1979;254:2214–2220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">429281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahadev K., Wu X., Zilbering A., Zhu L., Lawrence J.T.R., Goldstein B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 2001;276:48662–48669. doi: 10.1074/jbc.M105061200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M105061200</ArticleId>
            <ArticleId IdType="pubmed">11598110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007;87:245–313. doi: 10.1152/physrev.00044.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00044.2005</ArticleId>
            <ArticleId IdType="pubmed">17237347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahadev K., Motoshima H., Wu X., Ruddy J.M., Arnold R.S., Cheng G., Lambeth J.D., Goldstein B.J. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 2004;24:1844–1854. doi: 10.1128/mcb.24.5.1844-1854.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.24.5.1844-1854.2004</ArticleId>
            <ArticleId IdType="pmc">PMC350558</ArticleId>
            <ArticleId IdType="pubmed">14966267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinhorn B., Sartoretto J.L., Sorrentino A., Romero N., Kalwa H., Abel E.D., Michel T. Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4. Free Radic. Biol. Med. 2017;113:16–25. doi: 10.1016/j.freeradbiomed.2017.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.09.006</ArticleId>
            <ArticleId IdType="pmc">PMC5699944</ArticleId>
            <ArticleId IdType="pubmed">28917508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Mouche S., Sajic T., Veyrat-Durebex C., Supale R., Pierroz D., Ferrari S., Negro F., Hasler U., Feraille E., Moll S., Meda P., Deffert C., Montet X., Krause K.H., Szanto I. Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity. Int. J. Obes. 2012;36:1503–1513. doi: 10.1038/ijo.2011.279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ijo.2011.279</ArticleId>
            <ArticleId IdType="pubmed">22430302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park H.S., Jin D.K., Shin S.M., Jang M.K., Longo N., Park J.W., Bae D.S., Bae Y.S. Impaired generation of reactive oxygen species in leprechaunism through downregulation of Nox4. Diabetes. 2005;54:3175–3181. doi: 10.2337/diabetes.54.11.3175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.54.11.3175</ArticleId>
            <ArticleId IdType="pubmed">16249442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004;114:1752–1761. doi: 10.1172/JCI21625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI21625</ArticleId>
            <ArticleId IdType="pmc">PMC535065</ArticleId>
            <ArticleId IdType="pubmed">15599400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anvari E., Wikström P., Walum E., Welsh N. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice. Free Radic. Res. 2015;49:1308–1318. doi: 10.3109/10715762.2015.1067697.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10715762.2015.1067697</ArticleId>
            <ArticleId IdType="pubmed">26118714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark S., Konstantopoulos N. Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors. Biochem. J. 1993;292:217–223. doi: 10.1042/bj2920217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/bj2920217</ArticleId>
            <ArticleId IdType="pmc">PMC1134291</ArticleId>
            <ArticleId IdType="pubmed">8389126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmid E., El Benna J., Galter D., Klein G., Dröge W. Redox priming of the insulin receptor β‐chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J. 1998;12:863–870. doi: 10.1096/fasebj.12.10.863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fasebj.12.10.863</ArticleId>
            <ArticleId IdType="pubmed">9657526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmid E., Hotz‐Wagenblatt A., Hack V., Dröge W. Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide: the structural basis of redox priming. FASEB J. 1999;13:1491–1500. doi: 10.1096/fasebj.13.12.1491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fasebj.13.12.1491</ArticleId>
            <ArticleId IdType="pubmed">10463939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmitt T.L., Hotz-Wagenblatt A., Klein H., Dröge W. Interdependent regulation of insulin receptor kinase activity by ADP and hydrogen peroxide. J. Biol. Chem. 2005;280:3795–3801. doi: 10.1074/jbc.M410352200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M410352200</ArticleId>
            <ArticleId IdType="pubmed">15563471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S.R., Yang K.S., Kwon J., Lee C., Jeong W., Rhee S.G. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 2002;277:20336–20342. doi: 10.1074/jbc.M111899200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111899200</ArticleId>
            <ArticleId IdType="pubmed">11916965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon J., Lee S.R., Yang K.S., Ahn Y., Kim Y.J., Stadtman E.R., Rhee S.G. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. U.S.A. 2004;101:16419–16424. doi: 10.1073/pnas.0407396101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0407396101</ArticleId>
            <ArticleId IdType="pmc">PMC534546</ArticleId>
            <ArticleId IdType="pubmed">15534200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seo J.H., Ahn Y., Lee S.-R., Yeo C.Y., Hur K.C. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol. Biol. Cell. 2005;16:348–357. doi: 10.1091/mbc.e04-05-0369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.e04-05-0369</ArticleId>
            <ArticleId IdType="pmc">PMC539178</ArticleId>
            <ArticleId IdType="pubmed">15537704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature. 2003;423:769–773. doi: 10.1038/nature01680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01680</ArticleId>
            <ArticleId IdType="pubmed">12802338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wani R., Qian J., Yin L., Bechtold E., King S.B., Poole L.B., Paek E., Tsang A.W., Furdui C.M. Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 2011;108:10550–10555. doi: 10.1073/pnas.1011665108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1011665108</ArticleId>
            <ArticleId IdType="pmc">PMC3127936</ArticleId>
            <ArticleId IdType="pubmed">21670275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang X., Begley M., Morgenstern K.A., Gu Y., Rose P., Zhao H., Zhu X. Crystal structure of an inactive Akt2 kinase domain. Structure. 2003;11:21–30. doi: 10.1016/S0969-2126(02)00937-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0969-2126(02)00937-1</ArticleId>
            <ArticleId IdType="pubmed">12517337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 2003;278:50226–50233. doi: 10.1074/jbc.M310171200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M310171200</ArticleId>
            <ArticleId IdType="pubmed">14522978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsitsipatis D., Gopal K., Steinbrenner H., Klotz L.O. FOXO1 cysteine-612 mediates stimulatory effects of the coregulators CBP and PGC1α on FOXO1 basal transcriptional activity. Free Radic. Biol. Med. 2018;118:98–107. doi: 10.1016/j.freeradbiomed.2018.02.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.02.034</ArticleId>
            <ArticleId IdType="pubmed">29496617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sewastianik T., Szydlowski M., Jablonska E., Bialopiotrowicz E., Kiliszek P., Gorniak P., Polak A., Prochorec-Sobieszek M., Szumera-Cieckiewicz A., Kaminski T.S., Markowicz S., Nowak E., Grygorowicz M.A., Warzocha K., Juszczynski P. FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism. Oncogene. 2016;35:5989–6000. doi: 10.1038/onc.2016.126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2016.126</ArticleId>
            <ArticleId IdType="pubmed">27132507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hopkins B.L., Nadler M., Skoko J.J., Bertomeu T., Pelosi A., Shafaei P.M., Levine K., Schempf A., Pennarun B., Yang B., Datta D., Bucur O., Ndebele K., Oesterreich S., Yang D., Giulia Rizzo M., Khosravi-Far R., Neumann C.A. A peroxidase peroxiredoxin 1-specific redox regulation of the novel FOXO3 microRNA target let-7. Antioxid. Redox Signal. 2018;28:62–77. doi: 10.1089/ars.2016.6871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2016.6871</ArticleId>
            <ArticleId IdType="pmc">PMC5695745</ArticleId>
            <ArticleId IdType="pubmed">28398822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dansen T.B., Smits L.M.M., Van Triest M.H., De Keizer P.L.J., Van Leenen D., Koerkamp M.G., Szypowska A., Meppelink A., Brenkman A.B., Yodoi J., Holstege F.C.P., Burgering B.M.T. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 2009;5:664–672. doi: 10.1038/nchembio.194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.194</ArticleId>
            <ArticleId IdType="pubmed">19648934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Putker M., Madl T., Vos H.R., de Ruiter H., Visscher M., van den Berg M.C.W., Kaplan M., Korswagen H.C., Boelens R., Vermeulen M., Burgering B.M.T., Dansen T.B. Redox-dependent control of FOXO/DAF-16 by transportin-1. Mol. Cell. 2013;49:730–742. doi: 10.1016/j.molcel.2012.12.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2012.12.014</ArticleId>
            <ArticleId IdType="pubmed">23333309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowalski A., Gazzano H., Fehlmann M., Van Obberghen E. Dephosphorylation of the hepatic insulin receptor: absence of intrinsic phosphatase activity in purified receptors. Biochem. Biophys. Res. Commun. 1983;117:885–893. doi: 10.1016/0006-291X(83)91679-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-291X(83)91679-0</ArticleId>
            <ArticleId IdType="pubmed">6320818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haring H.U., Kasuga M., White M.F., Crettaz M., Kahn C.R. Phosphorylation and dephosphorylation of the insulin receptor: evidence against an intrinsic phosphatase activity. Biochemistry. 1984;23:3298–3306. doi: 10.1021/bi00309a028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi00309a028</ArticleId>
            <ArticleId IdType="pubmed">6087892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrett W.C., DeGnore J.P., Keng Y.F., Zhang Z.Y., Yim M.B., Chock P.B. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J. Biol. Chem. 1999;274:34543–34546. doi: 10.1074/jbc.274.49.34543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.49.34543</ArticleId>
            <ArticleId IdType="pubmed">10574916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dagnell M., Frijhoff J., Pader I., Augsten M., Boivin B., Xu J., Mandal P.K., Tonks N.K., Hellberg C., Conrad M., Arner E.S.J., Ostman A. Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-β receptor tyrosine kinase signaling. Proc. Natl. Acad. Sci. U.S.A. 2013;110:13398–13403. doi: 10.1073/pnas.1302891110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1302891110</ArticleId>
            <ArticleId IdType="pmc">PMC3746926</ArticleId>
            <ArticleId IdType="pubmed">23901112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J.O., Yang H., Georgescu M.M., Di Cristofano A., Maehama T., Shi Y., Dixon J.E., Pandolfi P., Pavletich N.P. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell. 1999;99:323–334. doi: 10.1016/S0092-8674(00)81663-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)81663-3</ArticleId>
            <ArticleId IdType="pubmed">10555148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li D.M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res. 1997;57:2124–2129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9187108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–1947. doi: 10.1126/science.275.5308.1943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.275.5308.1943</ArticleId>
            <ArticleId IdType="pubmed">9072974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maehama T., Taylor G.S., Dixon J.E. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu. Rev. Biochem. 2001;70:247–279. doi: 10.1146/annurev.biochem.70.1.247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.biochem.70.1.247</ArticleId>
            <ArticleId IdType="pubmed">11395408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leslie N.R., Bennett D., Lindsay Y.E., Stewart H., Gray A., Downes C.P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J. 2003;22:5501–5510. doi: 10.1093/emboj/cdg513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/emboj/cdg513</ArticleId>
            <ArticleId IdType="pmc">PMC213768</ArticleId>
            <ArticleId IdType="pubmed">14532122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim Y., Song Y.B., Kim T.Y., Kim I., Han S.J., Ahn Y., Cho S.H., Choi C.Y., Chay K.O., Yang S.Y., Ahn B.W., Huh W.K., Lee S.R. Redox regulation of the tumor suppressor PTEN by glutathione. FEBS Lett. 2010;584:3550–3556. doi: 10.1016/j.febslet.2010.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2010.07.006</ArticleId>
            <ArticleId IdType="pubmed">20637195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross S.H., Lindsay Y., Safrany S.T., Lorenzo O., Villa F., Toth R., Clague M.J., Downes C.P., Leslie N.R. Differential redox regulation within the PTP superfamily. Cell. Signal. 2007;19:1521–1530. doi: 10.1016/j.cellsig.2007.01.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2007.01.026</ArticleId>
            <ArticleId IdType="pubmed">17346927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J.H., Park S.J., Chae U., Seong J., Lee H.S., Lee S.R., Lee S., Lee D.S. Peroxiredoxin 2 mediates insulin sensitivity of skeletal muscles through regulation of protein tyrosine phosphatase oxidation. Int. J. Biochem. Cell Biol. 2018;99:80–90. doi: 10.1016/j.biocel.2018.03.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2018.03.019</ArticleId>
            <ArticleId IdType="pubmed">29605633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mueller A.S., Bosse A.C., Most E., Klomann S.D., Schneider S., Pallauf J. Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats. J. Nutr. Biochem. 2009;20:235–247. doi: 10.1016/j.jnutbio.2008.02.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jnutbio.2008.02.007</ArticleId>
            <ArticleId IdType="pubmed">18602818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koren S., Fantus I.G. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract. Res. Clin. Endocrinol. Metab. 2007;21:621–640. doi: 10.1016/j.beem.2007.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.beem.2007.08.004</ArticleId>
            <ArticleId IdType="pubmed">18054739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283:1544–1548. doi: 10.1126/science.283.5407.1544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.283.5407.1544</ArticleId>
            <ArticleId IdType="pubmed">10066179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 2000;20:5479–5489. doi: 10.1128/mcb.20.15.5479-5489.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.20.15.5479-5489.2000</ArticleId>
            <ArticleId IdType="pmc">PMC85999</ArticleId>
            <ArticleId IdType="pubmed">10891488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ali M.I., Ketsawatsomkron P., Belin de Chantelemele E.J., James D., Muta K., Salet C., Black S.M., Tremblay M.L., David J., Ph D., Marrero M.B., Stepp D.W. Deletion of protein tyrosin phosphatase 1B improves peripheral insulin resistance and vascular function in obese, leptin resistant mice via reduced oxidant tone. Circ. Res. 2009;105:706–721. doi: 10.1161/CIRCRESAHA.109.206318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.109.206318</ArticleId>
            <ArticleId IdType="pmc">PMC2783580</ArticleId>
            <ArticleId IdType="pubmed">19797171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ostman A., Frijhoff J., Sandin A., Böhmer F.D. Regulation of protein tyrosine phosphatases by reversible oxidation. J. Biochem. 2011;150:345–356. doi: 10.1093/jb/mvr104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jb/mvr104</ArticleId>
            <ArticleId IdType="pubmed">21856739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popov D. Endoplasmic reticulum stress and the on site function of resident PTP1B. Biochem. Biophys. Res. Commun. 2012;422:535–538. doi: 10.1016/j.bbrc.2012.05.048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2012.05.048</ArticleId>
            <ArticleId IdType="pubmed">22609202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boubekeur S., Boute N., Pagesy P., Zilberfarb V., Christeff N., Issad T. A new highly efficient substrate-trapping mutant of protein tyrosine phosphatase 1B (PTP1B) reveals full autoactivation of the insulin receptor precursor. J. Biol. Chem. 2011;286:19373–19380. doi: 10.1074/jbc.M111.222984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.222984</ArticleId>
            <ArticleId IdType="pmc">PMC3103315</ArticleId>
            <ArticleId IdType="pubmed">21487008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Issad T., Boute N., Boubekeur S., Lacasa D. Interaction of PTPB with the insulin receptor precursor during its biosynthesis in the endoplasmic reticulum. Biochimie. 2005;87:111–116. doi: 10.1016/j.biochi.2004.12.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biochi.2004.12.008</ArticleId>
            <ArticleId IdType="pubmed">15733745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bettaieb A., Bakke J., Nagata N., Matsuo K., Xi Y., Liu S., Aboubechara D., Melhem R., Stanhope K., Cummings B., Graham J., Bremer A., Zhang S., Lyssiotis C.A., Zhang Z.Y., Cantley L.C., Havel P.J., Haj F.G. Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation. J. Biol. Chem. 2013;288:17360–17371. doi: 10.1074/jbc.M112.441469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.441469</ArticleId>
            <ArticleId IdType="pmc">PMC3682537</ArticleId>
            <ArticleId IdType="pubmed">23640882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006;7:833–846. doi: 10.1038/nrm2039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm2039</ArticleId>
            <ArticleId IdType="pubmed">17057753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrer-Sueta G., Manta B., Botti H., Radi R., Trujillo M., Denicola A. Factors affecting protein thiol reactivity and specificity in peroxide reduction. Chem. Res. Toxicol. 2011;24:434–450. doi: 10.1021/tx100413v.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/tx100413v</ArticleId>
            <ArticleId IdType="pubmed">21391663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrett W.C., DeGnore J.P., König S., Fales H.M., Keng Y.F., Zhang Z.Y., Yim M.B., Chock P.B. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry. 1999;38:6699–6705. doi: 10.1021/bi990240v.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi990240v</ArticleId>
            <ArticleId IdType="pubmed">10350489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Townsend D.M., Findlay V.J., Fazilev F., Ogle M., Fraser J., Saavedra J.E., Ji X., Keefer L.K., Tew K.D. A glutathione S-transferase π-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol. Pharmacol. 2006;69:501–508. doi: 10.1124/mol.105.018523.a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mol.105.018523.a</ArticleId>
            <ArticleId IdType="pmc">PMC6522256</ArticleId>
            <ArticleId IdType="pubmed">16288082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Denu J.M., Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry. 1998;37:5633–5642. doi: 10.1021/bi973035t.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi973035t</ArticleId>
            <ArticleId IdType="pubmed">9548949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juarez J.C., Manuia M., Burnett M.E., Betancourt O., Boivin B., Shaw D.E., Tonks N.K., Mazar A.P., Doñate F. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U.S.A. 2008;105:7147–7152. doi: 10.1073/pnas.0709451105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0709451105</ArticleId>
            <ArticleId IdType="pmc">PMC2438219</ArticleId>
            <ArticleId IdType="pubmed">18480265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forman H.J., Maiorino M., Ursini F. Signaling functions of reactive oxygen species. Biochemistry. 2010;49:835–842. doi: 10.1021/bi9020378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi9020378</ArticleId>
            <ArticleId IdType="pmc">PMC4226395</ArticleId>
            <ArticleId IdType="pubmed">20050630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanner J.J., Parsons Z.D., Cummings A.H., Zhou H., Gates K.S. Redox regulation of protein tyrosine phosphatases: structural and chemical aspects. Antioxid. Redox Signal. 2011;15:77–97. doi: 10.1089/ars.2010.3611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2010.3611</ArticleId>
            <ArticleId IdType="pubmed">20919935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Londhe A.D., Bergeron A., Curley S.M., Zhang F., Rivera K.D., Kannan A., Coulis G., Rizvi S.H.M., Kim S.J., Pappin D.J., Tonks N.K., Linhardt R.J., Boivin B. Regulation of PTP1B activation through disruption of redox-complex formation. Nat. Chem. Biol. 2020;16:122–125. doi: 10.1038/s41589-019-0433-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41589-019-0433-0</ArticleId>
            <ArticleId IdType="pmc">PMC6982540</ArticleId>
            <ArticleId IdType="pubmed">31873221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimizu S., Ugi S., Maegawa H., Egawa K., Nishio Y., Yoshizaki T., Shi K., Nagai Y., Morino K., Nemoto K., Nakamura T., Bryer-Ash M., Kashiwagi A. Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J. Biol. Chem. 2003;278:43095–43101. doi: 10.1074/jbc.M306880200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M306880200</ArticleId>
            <ArticleId IdType="pubmed">12941932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferré P., Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res. 2007;68:72–82. doi: 10.1159/000100426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000100426</ArticleId>
            <ArticleId IdType="pubmed">17344645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell. Signal. 2000;12:583–594. doi: 10.1016/s0898-6568(00)00110-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0898-6568(00)00110-8</ArticleId>
            <ArticleId IdType="pubmed">11080610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diraison F., Parton L., Ferré P., Foufelle F., Briscoe C.P., Leclerc I., Rutter G.A. Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose- stimulated insulin release: modulation by 5-aminoimidazole- 4-carboxamide ribonucleoside (AICAR) Biochem. J. 2004;778:769–778. doi: 10.1042/BJ20031277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20031277</ArticleId>
            <ArticleId IdType="pmc">PMC1224038</ArticleId>
            <ArticleId IdType="pubmed">14690455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H., Maechler P., Antinozzi P.A., Herrero L., Hagenfeldt-Johansson K.A., Björklund A., Wollheim C.B. The transcription factor SREBP-1c is instrumental in the development of β-cell dysfunction. J. Biol. Chem. 2003;278:16622–16629. doi: 10.1074/jbc.M212488200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M212488200</ArticleId>
            <ArticleId IdType="pubmed">12600983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnan N., Bonham C.A., Rus I.A., Shrestha O.K., Gauss C.M., Haque A., Tocilj A., Joshua-Tor L., Tonks N.K. Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development. Nat. Commun. 2018;9:283. doi: 10.1038/s41467-017-02252-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-017-02252-2</ArticleId>
            <ArticleId IdType="pmc">PMC5773487</ArticleId>
            <ArticleId IdType="pubmed">29348454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galbo T., Perry R.J., Nishimura E., Samuel V.T., Quistorff B., Shulman G.I. PP2A inhibition results in hepatic insulin resistance despite Akt2 activation. Aging (Albany NY) 2013;5:770–781. doi: 10.18632/aging.100611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.100611</ArticleId>
            <ArticleId IdType="pmc">PMC3838779</ArticleId>
            <ArticleId IdType="pubmed">24150286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao R.K., Clayton L.W. Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem. Biophys. Res. Commun. 2002;293:610–616. doi: 10.1016/S0006-291X(02)00268-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-291X(02)00268-1</ArticleId>
            <ArticleId IdType="pubmed">12054646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guy G.R., Cairns J., Ng S.B., Tan Y.H. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 1993;268:2141–2148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8380591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng X., Cartee G.D. Insulin-induced effects on the subcellular localization of AKT1, AKT2 and AS160 in rat skeletal muscle. Sci. Rep. 2016;6:39230. doi: 10.1038/srep39230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep39230</ArticleId>
            <ArticleId IdType="pmc">PMC5155274</ArticleId>
            <ArticleId IdType="pubmed">27966646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altomare D.A., Lyons G.E., Mitsuuchi Y., Cheng J.Q., Testa J.R. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene. 1998;16:2407–2411. doi: 10.1038/sj.onc.1201750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1201750</ArticleId>
            <ArticleId IdType="pubmed">9620559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang J., Cron P., Thompson V., Good V.M., Hess D., Hemmings B.A., Barford D. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell. 2002;9:1227–1240. doi: 10.1016/S1097-2765(02)00550-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00550-6</ArticleId>
            <ArticleId IdType="pubmed">12086620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebner M., Lučić I., Leonard T.A., Yudushkin I. PI(3,4,5)P3 engagement restricts Akt activity to cellular membranes. Mol. Cell. 2017;65:416–431.e6. doi: 10.1016/j.molcel.2016.12.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2016.12.028</ArticleId>
            <ArticleId IdType="pubmed">28157504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Tao L., Hai C.X. Redox-regulating role of insulin: the essence of insulin effect. Mol. Cell. Endocrinol. 2012;349:111–127. doi: 10.1016/j.mce.2011.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mce.2011.08.019</ArticleId>
            <ArticleId IdType="pubmed">21878367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brigelius-Flohé R., Flohé L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 2011;15:2335–2381. doi: 10.1089/ars.2010.3534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2010.3534</ArticleId>
            <ArticleId IdType="pmc">PMC3166203</ArticleId>
            <ArticleId IdType="pubmed">21194351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dodson M., de la Vega M.R., Cholanians A.B., Schmidlin C.J., Chapman E., Zhang D.D. Modulating NRF2 in disease: timing is everything. Annu. Rev. Pharmacol. Toxicol. 2019;59:555–575. doi: 10.1146/annurev-pharmtox-010818-021856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-pharmtox-010818-021856</ArticleId>
            <ArticleId IdType="pmc">PMC6538038</ArticleId>
            <ArticleId IdType="pubmed">30256716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001;2:769–776. doi: 10.1038/35096075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35096075</ArticleId>
            <ArticleId IdType="pubmed">11584304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu G., He X. Threonine 41 in β-catenin serves as a key phosphorylation relay residue in β-catenin degradation. Biochemistry. 2006;45:5319–5323. doi: 10.1021/bi0601149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi0601149</ArticleId>
            <ArticleId IdType="pubmed">16618120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chowdhry S., Zhang Y., McMahon M., Sutherland C., Cuadrado A., Hayes J.D. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene. 2013;32:3765–3781. doi: 10.1038/onc.2012.388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2012.388</ArticleId>
            <ArticleId IdType="pmc">PMC3522573</ArticleId>
            <ArticleId IdType="pubmed">22964642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rojo A.I., Rada P., Mendiola M., Ortega-Molina A., Wojdyla K., Rogowska-Wrzesinska A., Hardisson D., Serrano M., Cuadrado A. The PTEN/NRF2 axis promotes human carcinogenesis. Antioxid. Redox Signal. 2014;21:2498–2514. doi: 10.1089/ars.2014.5843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2014.5843</ArticleId>
            <ArticleId IdType="pmc">PMC4245871</ArticleId>
            <ArticleId IdType="pubmed">24892215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain A.K., Jaiswal A.K. GSK-3β acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J. Biol. Chem. 2007;282:16502–16510. doi: 10.1074/jbc.M611336200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M611336200</ArticleId>
            <ArticleId IdType="pubmed">17403689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaspar J.W., Jaiswal A.K. Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression. FASEB J. 2011;25:1076–1087. doi: 10.1096/fj.10-171553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.10-171553</ArticleId>
            <ArticleId IdType="pmc">PMC3042843</ArticleId>
            <ArticleId IdType="pubmed">21097520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yagishita Y., Uruno A., Fukutomi T., Saito R., Saigusa D., Pi J., Fukamizu A., Sugiyama F., Takahashi S., Yamamoto M. Nrf2 improves leptin and insulin resistance provoked by hypothalamic oxidative stress. Cell Rep. 2017;18:2030–2044. doi: 10.1016/j.celrep.2017.01.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.01.064</ArticleId>
            <ArticleId IdType="pubmed">28228267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matzinger M., Fischhuber K., Heiss E.H. Activation of Nrf2 signaling by natural products-can it alleviate diabetes? Biotechnol. Adv. 2018;36:1738–1767. doi: 10.1016/j.biotechadv.2017.12.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biotechadv.2017.12.015</ArticleId>
            <ArticleId IdType="pmc">PMC5967606</ArticleId>
            <ArticleId IdType="pubmed">29289692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egea J., González-Rodríguez Á., Gómez-Guerrero C., Moreno J.A. Editorial: role of Nrf2 in disease: novel molecular mechanisms and therapeutic approaches. Front. Pharmacol. 2019;10:1149. doi: 10.3389/fphar.2019.01149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2019.01149</ArticleId>
            <ArticleId IdType="pmc">PMC6787767</ArticleId>
            <ArticleId IdType="pubmed">31636562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S., Eguchi N., Lau H., Ichii H. The role of the Nrf2 signaling in obesity and insulin resistance. Int. J. Mol. Sci. 2020;21:6973. doi: 10.3390/ijms21186973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21186973</ArticleId>
            <ArticleId IdType="pmc">PMC7555440</ArticleId>
            <ArticleId IdType="pubmed">32971975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tonelli C., Chio I.I.C., Tuveson D.A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal. 2018;29:1727–1745. doi: 10.1089/ars.2017.7342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2017.7342</ArticleId>
            <ArticleId IdType="pmc">PMC6208165</ArticleId>
            <ArticleId IdType="pubmed">28899199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tebay L.E., Robertson H., Durant S.T., Vitale S.R., Penning T.M., Dinkova-Kostova A.T., Hayes J.D. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic. Biol. Med. 2015;88:108–146. doi: 10.1016/j.freeradbiomed.2015.06.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.06.021</ArticleId>
            <ArticleId IdType="pmc">PMC4659505</ArticleId>
            <ArticleId IdType="pubmed">26122708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 2002;62:5196–5203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12234984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh A., Happel C., Manna S.K., Acquaah-Mensah G., Carrerero J., Kumar S., Nasipuri P., Krausz K.W., Wakabayashi N., Dewi R., Boros L.G., Gonzalez F.J., Gabrielson E., Wong K.K., Girnun G., Biswal S. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J. Clin. Invest. 2013;123:2921–2934. doi: 10.1172/JCI66353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI66353</ArticleId>
            <ArticleId IdType="pmc">PMC3696551</ArticleId>
            <ArticleId IdType="pubmed">23921124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng X., Siow R.C.M., Mann G.E. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid. Redox Signal. 2011;14:469–487. doi: 10.1089/ars.2010.3283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2010.3283</ArticleId>
            <ArticleId IdType="pubmed">20524845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aleksunes L.M., Reisman S.A., Yeager R.L., Goedken M.J., Klaassen C.D. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J. Pharmacol. Exp. Ther. 2010;333:140–151. doi: 10.1124/jpet.109.162271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/jpet.109.162271</ArticleId>
            <ArticleId IdType="pmc">PMC2846027</ArticleId>
            <ArticleId IdType="pubmed">20086057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uruno A., Furusawa Y., Yagishita Y., Fukutomi T., Muramatsu H., Negishi T., Sugawara A., Kensler T.W., Yamamoto M. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol. Cell. Biol. 2013;33:2996–3010. doi: 10.1128/mcb.00225-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.00225-13</ArticleId>
            <ArticleId IdType="pmc">PMC3719683</ArticleId>
            <ArticleId IdType="pubmed">23716596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li B., Liu S., Miao L., Cai L. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Exp. Diabetes Res. 2012;2012:216512. doi: 10.1155/2012/216512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/216512</ArticleId>
            <ArticleId IdType="pmc">PMC3356887</ArticleId>
            <ArticleId IdType="pubmed">22645602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Z., Wei Y., Gong J., Cho H., Park J.K., Sung E.R., Huang H., Wu L., Eberhart C., Handa J.T., Du Y., Kern T.S., Thimmulappa R., Barber A.J., Biswal S., Duh E.J. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia. 2014;57:204–213. doi: 10.1007/s00125-013-3093-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-013-3093-8</ArticleId>
            <ArticleId IdType="pmc">PMC4039644</ArticleId>
            <ArticleId IdType="pubmed">24186494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cui W., Bai Y., Miao X., Luo P., Chen Q., Tan Y., Rane M.J., Miao L., Cai L. Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation. Oxid. Med. Cell. Longev. 2012;2012:821936. doi: 10.1155/2012/821936.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/821936</ArticleId>
            <ArticleId IdType="pmc">PMC3461640</ArticleId>
            <ArticleId IdType="pubmed">23050040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang T., Huang Z., Lin Y., Zhang Z., Fang D., Zhang D.D. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes. 2010;59:850–860. doi: 10.2337/db09-1342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-1342</ArticleId>
            <ArticleId IdType="pmc">PMC2844833</ArticleId>
            <ArticleId IdType="pubmed">20103708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J., Sun X., Jiang Z., Jiang J., Xu L., Tian A., Sun X., Meng H., Li Y., Huang W., Jia Y., Wu H. Protective role of NRF2 in macrovascular complications of diabetes. J. Cell. Mol. Med. 2020;24:8903–8917. doi: 10.1111/jcmm.15583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.15583</ArticleId>
            <ArticleId IdType="pmc">PMC7417734</ArticleId>
            <ArticleId IdType="pubmed">32628815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z., Dou W., Ni Z., Wen Q., Zhang R., Qin M., Wang X., Tang H., Cao Y., Wang J., Zhao S. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet. Mol. Med. Rep. 2016;14:1323–1331. doi: 10.3892/mmr.2016.5393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2016.5393</ArticleId>
            <ArticleId IdType="pubmed">27315552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pi J., Leung L., Xue P., Wang W., Hou Y., Liu D., Yehuda-Shnaidman E., Lee C., Lau J., Kurtz T.W., Chan J.Y. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J. Biol. Chem. 2010;285:9292–9300. doi: 10.1074/jbc.M109.093955.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.093955</ArticleId>
            <ArticleId IdType="pmc">PMC2838347</ArticleId>
            <ArticleId IdType="pubmed">20089859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chartoumpekis D.V., Ziros P.G., Psyrogiannis A.I., Papavassiliou A.G., Kyriazopoulou V.E., Sykiotis G.P., Habeos I.G. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes. 2011;60:2465–2473. doi: 10.2337/db11-0112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db11-0112</ArticleId>
            <ArticleId IdType="pmc">PMC3178292</ArticleId>
            <ArticleId IdType="pubmed">21852674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meakin P.J., Chowdhry S., Sharma R.S., Ashford F.B., Walsh S.V., McCrimmon R.J., Dinkova-Kostova A.T., Dillon J.F., Hayes J.D., Ashford M.L.J. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol. Cell. Biol. 2014;34:3305–3320. doi: 10.1128/mcb.00677-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.00677-14</ArticleId>
            <ArticleId IdType="pmc">PMC4135558</ArticleId>
            <ArticleId IdType="pubmed">24958099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weigel D., Jürgens G., Küttner F., Seifert E., Jäckle H. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell. 1989;57:645–658. doi: 10.1016/0092-8674(89)90133-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(89)90133-5</ArticleId>
            <ArticleId IdType="pubmed">2566386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuyama T., Nakazawa T., Nakano I., Mori N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 2000;349:629–634. doi: 10.1042/0264-6021:3490629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/0264-6021:3490629</ArticleId>
            <ArticleId IdType="pmc">PMC1221187</ArticleId>
            <ArticleId IdType="pubmed">10880363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Vos K.E., Coffer P.J. FOXO-binding partners: it takes two to tango. Oncogene. 2008;27:2289–2299. doi: 10.1038/onc.2008.22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2008.22</ArticleId>
            <ArticleId IdType="pubmed">18391971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eijkelenboom A., Burgering B.M.T. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 2013;14:83–97. doi: 10.1038/nrm3507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3507</ArticleId>
            <ArticleId IdType="pubmed">23325358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lettieri-Barbato D., Ioannilli L., Aquilano K., Ciccarone F., Rosina M., Ciriolo M.R. FoxO1 localizes to mitochondria of adipose tissue and is affected by nutrient stress. Metabolism. 2019;95:84–92. doi: 10.1016/j.metabol.2019.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.metabol.2019.04.006</ArticleId>
            <ArticleId IdType="pubmed">30974111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klotz L.O., Sánchez-Ramos C., Prieto-Arroyo I., Urbánek P., Steinbrenner H., Monsalve M. Redox regulation of FoxO transcription factors. Redox Biol. 2015;6:51–72. doi: 10.1016/j.redox.2015.06.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2015.06.019</ArticleId>
            <ArticleId IdType="pmc">PMC4511623</ArticleId>
            <ArticleId IdType="pubmed">26184557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barthel A., Schmoll D., Unterman T.G. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 2005;16:183–189. doi: 10.1016/j.tem.2005.03.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tem.2005.03.010</ArticleId>
            <ArticleId IdType="pubmed">15860415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gross D.N., van den Heuvel A.P.J., Birnbaum M.J. The role of FoxO in the regulation of metabolism. Oncogene. 2008;27:2320–2336. doi: 10.1038/onc.2008.25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2008.25</ArticleId>
            <ArticleId IdType="pubmed">18391974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V.E., Arden K.C., Accili D. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 2002;32:245–253. doi: 10.1038/ng890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng890</ArticleId>
            <ArticleId IdType="pubmed">12219087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barbato D.L., Tatulli G., Aquilano K., Ciriolo M.R. Mitochondrial Hormesis links nutrient restriction to improved metabolism in fat cell. Aging (Albany NY) 2015;7:869–881. doi: 10.18632/aging.100832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.100832</ArticleId>
            <ArticleId IdType="pmc">PMC4637211</ArticleId>
            <ArticleId IdType="pubmed">26540513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Notredame C., Higgins D.G., Heringa J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 2000;302:205–217. doi: 10.1006/jmbi.2000.4042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/jmbi.2000.4042</ArticleId>
            <ArticleId IdType="pubmed">10964570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clamp M., Cuff J., Searle S.M., Barton G.J. The Jalview Java alignment editor. Bioinformatics. 2004;20:426–427. doi: 10.1093/bioinformatics/btg430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/btg430</ArticleId>
            <ArticleId IdType="pubmed">14960472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Partridge L., Alic N., Bjedov I., Piper M.D.W. Ageing in Drosophila: the role of the insulin/Igf and TOR signalling network. Exp. Gerontol. 2011;46:376–381. doi: 10.1016/j.exger.2010.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exger.2010.09.003</ArticleId>
            <ArticleId IdType="pmc">PMC3087113</ArticleId>
            <ArticleId IdType="pubmed">20849947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos. Trans. R. Soc. B Biol. Sci. 2011;366:9–16. doi: 10.1098/rstb.2010.0276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rstb.2010.0276</ArticleId>
            <ArticleId IdType="pmc">PMC3001308</ArticleId>
            <ArticleId IdType="pubmed">21115525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell. 2005;120:449–460. doi: 10.1016/j.cell.2005.02.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2005.02.002</ArticleId>
            <ArticleId IdType="pubmed">15734678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alic N., Partridge L. Death and dessert: nutrient signalling pathways and ageing. Curr. Opin. Cell Biol. 2011;23:738–743. doi: 10.1016/j.ceb.2011.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2011.07.006</ArticleId>
            <ArticleId IdType="pmc">PMC4335171</ArticleId>
            <ArticleId IdType="pubmed">21835601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marino S.M., Gladyshev V.N. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J. Mol. Biol. 2010;404:902–916. doi: 10.1016/j.jmb.2010.09.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmb.2010.09.027</ArticleId>
            <ArticleId IdType="pmc">PMC3061813</ArticleId>
            <ArticleId IdType="pubmed">20950627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Dam E., van Leeuwen L.A.G., dos Santos E., James J., Best L., Lennicke C., Vincent A.J., Marinos G., Foley A., Buricova M., Mokochinski J.B., Kramer H.B., Lieb W., Laudes M., Franke A., Kaleta C., Cochemé H.M. Sugar-induced obesity and insulin resistance are uncoupled from shortened survival in Drosophila. Cell Metab. 2020;31:710–725.e7. doi: 10.1016/j.cmet.2020.02.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2020.02.016</ArticleId>
            <ArticleId IdType="pmc">PMC7156915</ArticleId>
            <ArticleId IdType="pubmed">32197072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarse K., Schmeisser S., Groth M., Priebe S., Beuster G., Kuhlow D., Guthke R., Platzer M., Kahn C.R., Ristow M. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 2012;15:451–465. doi: 10.1016/j.cmet.2012.02.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.02.013</ArticleId>
            <ArticleId IdType="pmc">PMC4844853</ArticleId>
            <ArticleId IdType="pubmed">22482728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menger K.E., James A.M., Cochemé H.M., Harbour M.E., Chouchani E.T., Ding S., Fearnley I.M., Partridge L., Murphy M.P. Fasting, but not aging, dramatically alters the redox status of cysteine residues on proteins in Drosophila melanogaster. Cell Rep. 2015;11:1856–1865. doi: 10.1016/j.celrep.2015.05.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.05.033</ArticleId>
            <ArticleId IdType="pmc">PMC4508341</ArticleId>
            <ArticleId IdType="pubmed">26095360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musselman L.P., Kühnlein R.P. Drosophila as a model to study obesity and metabolic disease. J. Exp. Biol. 2018;221:jeb163881. doi: 10.1242/jeb.163881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jeb.163881</ArticleId>
            <ArticleId IdType="pubmed">29514880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regan J.C., Partridge L. Gender and longevity: why do men die earlier than women? Comparative and experimental evidence. Best Pract. Res. Clin. Endocrinol. Metab. 2013;27:467–479. doi: 10.1016/j.beem.2013.05.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.beem.2013.05.016</ArticleId>
            <ArticleId IdType="pubmed">24054925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajan A., Perrimon N. Of flies and men: insights on organismal metabolism from fruit flies. BMC Biol. 2013;11:38. doi: 10.1186/1741-7007-11-38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1741-7007-11-38</ArticleId>
            <ArticleId IdType="pmc">PMC3626883</ArticleId>
            <ArticleId IdType="pubmed">23587196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennicke C., Cochemé H.M. Redox signalling and ageing: insights from Drosophila. Biochem. Soc. Trans. 2020;48:367–377. doi: 10.1042/BST20190052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BST20190052</ArticleId>
            <ArticleId IdType="pmc">PMC7200633</ArticleId>
            <ArticleId IdType="pubmed">32196546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., Stumvoll M., Kahn C.R., Blüher M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. U.S.A. 2009;106:8665–8670. doi: 10.1073/pnas.0903485106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0903485106</ArticleId>
            <ArticleId IdType="pmc">PMC2680430</ArticleId>
            <ArticleId IdType="pubmed">19433800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bashan N., Kovsan J., Kachko I., Ovadia H., Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol. Rev. 2009;89:27–71. doi: 10.1152/physrev.00014.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00014.2008</ArticleId>
            <ArticleId IdType="pubmed">19126754</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
